These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 25339666

  • 1. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.
    Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C, Staude H, Wechselberger G, Edelbauer M.
    J Immunol; 2014 Nov 15; 193(10):4895-903. PubMed ID: 25339666
    [Abstract] [Full Text] [Related]

  • 2. CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathway.
    Maeda K, Kosugi T, Sato W, Kojima H, Sato Y, Kamimura D, Kato N, Tsuboi N, Yuzawa Y, Matsuo S, Murakami M, Maruyama S, Kadomatsu K.
    Arthritis Rheumatol; 2015 May 15; 67(8):2185-95. PubMed ID: 25891969
    [Abstract] [Full Text] [Related]

  • 3. Enhanced activity of Akt in Teff cells from children with lupus nephritis is associated with reduced induction of tumor necrosis factor receptor-associated factor 6 and increased OX40 expression.
    Kshirsagar S, Binder E, Riedl M, Wechselberger G, Steichen E, Edelbauer M.
    Arthritis Rheum; 2013 Nov 15; 65(11):2996-3006. PubMed ID: 23896866
    [Abstract] [Full Text] [Related]

  • 4. Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.
    Pawaria S, Ramani K, Maers K, Liu Y, Kane LP, Levesque MC, Biswas PS.
    J Immunol; 2014 Oct 01; 193(7):3288-95. PubMed ID: 25149466
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N, Popp FC, Soeder Y, Haarer J, Geissler EK, Schlitt HJ, Dahlke MH.
    J Immunol; 2014 Nov 15; 193(10):4988-99. PubMed ID: 25305313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
    Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, Olivier M, Piccirillo CA.
    PLoS One; 2012 Nov 15; 7(4):e35572. PubMed ID: 22545118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T.
    Int Immunol; 2007 Jun 15; 19(6):695-702. PubMed ID: 17493959
    [Abstract] [Full Text] [Related]

  • 13. A77 1726, the active metabolite of leflunomide, attenuates lupus nephritis by promoting the development of regulatory T cells and inhibiting IL-17-producing double negative T cells.
    Qiao G, Yang L, Li Z, Williams JW, Zhang J.
    Clin Immunol; 2015 Apr 15; 157(2):166-74. PubMed ID: 25638413
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis.
    Ge F, Wang F, Yan X, Li Z, Wang X.
    Mol Med Rep; 2017 Nov 15; 16(5):5793-5798. PubMed ID: 28849060
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
    Liang CL, Lu W, Zhou JY, Chen Y, Zhang Q, Liu H, Qiu F, Dai Z.
    Cell Physiol Biochem; 2018 Nov 15; 50(4):1560-1573. PubMed ID: 30359968
    [Abstract] [Full Text] [Related]

  • 18. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S, AlFailakawi A, Ghanem AA.
    Int J Rheum Dis; 2016 May 15; 19(5):512-20. PubMed ID: 25496163
    [Abstract] [Full Text] [Related]

  • 19. Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effect.
    Jimeno R, Leceta J, Garín M, Ortiz AM, Mellado M, Rodríguez-Frade JM, Martínez C, Pérez-García S, Gomariz RP, Juarranz Y.
    J Leukoc Biol; 2015 Aug 15; 98(2):257-69. PubMed ID: 25957307
    [Abstract] [Full Text] [Related]

  • 20. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY, Luo M, Lin XJ, Xu YL, Tang C, Ye JH, Li WN, He ZX, Yu N.
    Zhonghua Yi Xue Za Zhi; 2012 Feb 21; 92(7):460-3. PubMed ID: 22490966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.